Date: 2016-02-09
Type of information: Nomination
Compound:
Company: Amicus Therapeutics (USA - NJ)
Therapeutic area: Rare diseases - Genetic diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On February 9, 2016, Amicus Therapeutics announced that the company has strengthened its executive leadership with the addition of two new members with significant experience in rare disease. Ellen S. Rosenberg, a biopharmaceutical legal executive with strong commercial experience has been appointed General Counsel and Corporate Secretary and Kurt J.W. Andrews has been named Senior Vice President, Human Resources. Both Ms. Rosenberg and Mr. Andrews will report to John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics, Inc. Ellen S. Rosenberg - General Counsel and Corporate Secretary, will have global responsibility for all legal issues, provide counsel and advice to the leadership team, and provide legal oversight for the commercial expansion at Amicus. She has more than 25 years of legal experience in the biopharmaceutical and medical device industry. Ms. Rosenberg joins Amicus from Shire Pharmaceuticals, LLC, where she most recently served as Senior Vice President, Associate General Counsel. In this role she functioned as the Head of Shire's U.S. legal group with responsibility for all legal matters arising from Shire's U.S. business, including mergers and acquisitions, product launches, risk management, and compliance matters. Prior to Shire, Ms. Rosenberg was Associate General Counsel for the Metabolic Endocrinology division at EMD Serono Inc., the U.S. affiliate of Merck KGaA. Ms. Rosenberg received a B.A. from the University of Connecticut and a J.D. from the University of Pennsylvania Law School. Kurt J.W. Andrews will be responsible for developing the human resources strategy and plans to support the Amicus vision, including organizational structure, talent development, compensation strategy, and efforts to recruit and retain top talent. He has more than 20 years of experience working in leadership roles at biotechnology and technology companies. He most recently served as Vice President, Human Resources at Valeritas, Inc., a commercial-stage medical technology company, where he helped lead the evolution of the organization's business and commercial strategy, implementation of organization-wide goals and strategies, performance management, and compensation planning. Previously Mr. Andrews was Vice President, Human Resources and Administration at PTC Therapeutics.
Financial terms:
Latest news:
